Indeed, we found that in mice bearing high tumour load and a high number of circulating PDCD1+ CTLs, blocking the PDCD1/PD-L inhibitory pathway resulted in enhanced clearance of the tumour cells. Here, PDCD1 is linked to neoplasm.